Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marina P. Boyarkina
Observed names:
M Boyarkina,
M P Boiarkina,
M P Boyarkina,
M. Boyarkina,
M. P. Boyarkina,
M.P. Boyarkina,
Marina P Boyarkina,
М. П. Бояркина
show all 8
Institutions:
Ministry of Emergency Situations,
Nikiforov Russian Center of Emergency and Radiation Medicine
Observed institutions:
Ministry of Emergency Situations,
Institute of Oncology NN Petrov,
Ministry of Health of the Russian Federation,
Nikiforov Russian Center of Emergency and Radiation Medicine
OpenAlex ID:
A5113581892
More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin
2010
·
Lev M. Berstein
, Marina P. Boyarkina
, et al.
·
Medical Oncology
·
41
Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
2011
·
Lev M. Berstein
, Marina P. Boyarkina
, et al.
·
Medical Oncology
·
21
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women].
2012
·
L M Bershteĭn
, D A Vasil'ev
, et al.
·
PubMed
·
8
[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer].
2011
·
L M Bershteĭn
, S Ia Maksimov
, et al.
·
PubMed
·
7
Excretion of estrogens, catecholestrogens and phytoestrogens in carriers of BRCA1 gene mutations: effects of metformin
2010
·
L. Berstein
, A. Koskela
, et al.
·
Neoplasma
·
7
Hormonal-metabolic Pattern of Postmenopausal Females With New Onset of Diabetes Mellitus Type 2: the Role of Cancer and Hereditary Predisposition to Diabetes
2013
·
L.M. Bershtein
, D.A. Vasil’ev
, et al.
·
Annals of the Russian academy of medical sciences
·
6
PDF
Potential and real ‘antineoplastic’ and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females
2015
·
Lev M Berstein
, Dmitry A Vasilyev
, et al.
·
Future Oncology
·
3
[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes].
2012
·
L M Bershteĭn
, E A Turkevich
, et al.
·
PubMed
·
3
Evaluation of the Proportion of Hormonal and Progenotoxic Effects of Estrogens and Glucose in Cancer Patients
2010
·
L. M. Berstein
, T. E. Poroshina
, et al.
·
Bulletin of Experimental Biology and Medicine
·
3
[Family diabetes and its consequences in cancer patients].
2013
·
L M Bershteĭn
, D A Vasil'ev
, et al.
·
PubMed
·
2
Endocrine Metabolic Disorders in Patients with Breast Cancer, Carriers of BRCA1 Gene Mutations
2012
·
L. M. Berstein
, M. P. Boyarkina
, et al.
·
Bulletin of Experimental Biology and Medicine
·
2
[Influence of metformin and N-acetylcysteine on hormonal and genotoxic effects of estrogens and glucose in convalescent cancer patients].
2010
·
L M Bershteĭn
, D A Vasil'ev
, et al.
·
PubMed
·
1
[Gail coefficient as a risk factor and prognosticator for the course of breast cancer: correlation with hormonal and metabolic parameters and clinical and morphologic features].
2008
·
M P Boiarkina
, E V Tsyrlina
, et al.
·
PubMed
·
1
[The dual (joker) function of glucose: study of its association with aging and glucose metabolism disorders].
2008
·
D A Vasil'ev
, T E Poroshina
, et al.
·
PubMed
·
1
Vitamins D and B12, homocysteine and laboratory markers of chronic atrophic gastritis in Chernobyl liquidators with metabolic syndrome
2024
·
S. S. Aleksanin
, N. A. Alkhutova
, et al.
·
Medico-Biological and Socio-Psychological Problems of Safety in Emergency Situations
PDF
Хирургическое стадирование местно-распространенного рака шейки матки
2013
·
Margarita Kargopolova
, С. Я. Максимов
, et al.
Surgical stading local – cervical cancer incidence
2013
·
M V Kargopolova
, S Y Maximov
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Prevalence of Familial Diabetes Differs between Type 2 Diabetes Mellitus Patients with Cancer and Those without Cancer
2011
·
Lev M Berstein
, Marina P Boyarkina
, et al.
·
The Endocrine Society eBooks
Urine Estrogens, Catecholestrogens and Phytoestrogens in BRCA1 Gene Mutations Carriers: Relation to Reactive Glycemia.
2010
·
L Berstein
, A Koskela
, et al.
·
The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego
[Gail's coefficient in breast cancer patients with respect to menstrual status, body mass and estrogen receptor pattern of tumor].
2004
·
L M Bershteĭn
, M P Boiarkina
, et al.
·
PubMed
Show more works
View as search
Works count:
20
Citation count:
106
H-index:
6
I10-index:
2
Year
Topic
Type
